Format

Send to

Choose Destination
Lancet Diabetes Endocrinol. 2017 Mar;5(3):158-159. doi: 10.1016/S2213-8587(17)30041-4. Epub 2017 Feb 9.

Strategies to improve the affordability of insulin in the USA.

Author information

1
Program on Regulation Therapeutics and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02120, USA. Electronic address: jluo1@partners.org.
2
Program on Regulation Therapeutics and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02120, USA.
3
Departments of Medicine and History of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
4
Department of Internal Medicine (Endocrinology), Yale School of Medicine and Yale-New Haven Hospital Center for Outcomes Research and Evaluation, New Haven, CT, USA.

Comment in

Comment on

PMID:
28189654
DOI:
10.1016/S2213-8587(17)30041-4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center